DISCOUNT ZERTIFIKAT - EDWARDS LIFESCIENCES Stock

Certificat

DE000PZ0VGK3

Market Closed - Deutsche Boerse AG 15:40:21 2024-06-14 EDT
69.94 EUR +0.37% Intraday chart for DISCOUNT ZERTIFIKAT - EDWARDS LIFESCIENCES
Current month+1.60%
1 month+1.73%
Date Price Change
24-06-14 69.94 +0.37%
24-06-13 69.68 +0.62%
24-06-12 69.25 -0.56%
24-06-11 69.64 +0.19%
24-06-10 69.51 +0.45%

Delayed Quote Deutsche Boerse AG

Last update June 14, 2024 at 03:40 pm

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying EDWARDS LIFESCIENCES CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PZ0VGK
ISINDE000PZ0VGK3
Date issued 2023-10-31
Cap 75 $
Last trading day 2024-06-21
Maturity 2024-06-21 (6 Days)
Parity 1 : 1
Emission price 59.4
Emission volume N/A
Payment day 2024-06-27
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 0.000000 %
Sideways yield 0.000000 %
Sideways yield pa 0.000000 %
Outperformance point- $
Break even 0.000000 €
Highest since issue 70.13
Lowest since issue 55.99
Distance Cap 12.29 $
Distance Cap %+14.08%
Max. earning-
Max. earning % 0.000000 %

Company Profile

Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (67.9%); - hemodynamic monitoring systems (15.5%); - other (16.6%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
More about the company

Ratings for Edwards Lifesciences Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Edwards Lifesciences Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
87.29 USD
Average target price
96.24 USD
Spread / Average Target
+10.25%
Consensus